Figure 1From: Azelnidipine protects myocardium in hyperglycemia-induced cardiac damageEffect of AZL treatment on serum cardiac markers in STZ-treated diabetic rats (A) Troponin I (B) CK-MB (C) CK-NAC (D) LDH (E) Uric acid levels. Values depict means ± SE for at least n = 8 animals in each group. * means p < 0.01 compared to control group and ** means p < 0.01 compared to STZ diabetic groupBack to article page